FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

HARMONYL
deserpidine
LOE Approaching
AbbVie
ORAL · TABLET
1957
NDA
30/100
HECTOROL
doxercalciferol
LOE Approaching
Sanofi
INJECTION · INJECTABLE
2000
NDA
30/100
HECTOROL
doxercalciferol
LOE Approaching
Sanofi
ORAL · CAPSULE
1999
NDA
30/100
HELICOSOL
urea c-13
LOE Approaching
GT Metabolic Solutions
ORAL · FOR SOLUTION
1999
NDA
30/100
HELIDAC
bismuth subsalicylate; metronidazole; tetracycline hydrochloride
LOE Approaching
R-Pharm US
ORAL · TABLET, CHEWABLE, TABLET, CAPSULE
1996
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2016
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2018
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2020
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2014
NDA
30/100
HELIUM, USP
helium
Peak
Advanced Solutions Life Sciences
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2021
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2019
NDA
30/100
HELIUM, USP
helium, oxygen
Peak
INHALATION · GAS
2013
NDA
30/100
HELIUM, USP
helium
Peak
INHALATION · GAS
2018
NDA
30/100
HEMABATE
carboprost tromethamine
LOE Approaching
Pfizer
INJECTION · INJECTABLE
postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management
1979
NDA
30/100
HEMICLOR
chlorthalidone
Growth
ORAL · TABLET
hypertension in adultsto lower blood pressure+1
2025
NDA
30/100
HEPARIN LOCK FLUSH
heparin sodium
LOE Approaching
Hikma
INJECTION · INJECTABLE
1974
NDA
30/100
HEPARIN LOCK FLUSH
heparin sodium
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1943
NDA
30/100
← PreviousPage 79 of 277Next →